Comparison of Smartphone-Based Music and Film Distraction Techniques on Postoperative Pain in Patients Undergoing Elective Surgery.

Pain Manag NursMay 21, 2026 (epub)
Clinical ResearchAnesthesiologyGeneral Surgery

Ali Zeidabadi, Tayebeh Mirzaei, Ali Ravari et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of smartphone-based music and film distraction techniques in reducing acute postoperative pain in 104 adults undergoing elective surgery. Both interventions significantly decreased pain intensity, with median visual analog scale scores dropping from 6 to 2 postintervention (p = .0001).

Key findings

  • Median visual analog scale scores decreased from 6 (IQR 5-7) preintervention to 2 (IQR 1-3) postintervention.
  • 32.7% of participants in the music group did not request analgesics within 24 hours.
  • 41.2% of participants in the film group did not request analgesics within 24 hours.

Why it matters

Incorporating smartphone-based distraction techniques into postoperative care may enhance pain management strategies, providing a low-cost and patient-centered approach to alleviate discomfort after surgery.

Source

PubMed · PMID 42167997

Published in Pain Manag Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Anesthesiology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.